Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan/HCTZ dosage comparison in hypertension
NCT00430950Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Feb 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of olmesartan, hydrochlorothiazide in essential hypertension, sponsored by Daiichi Sankyo Co., Ltd.. Started Feb 2007; status: completed.
02
Drugs
olmesartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00430950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430950.